Toddler toy firm VTech could face an in-depth competition probe after merging with close competitor Leapfrog, regulators have said.
The firms are two of the largest selling toddler learning toys in the UK, the Competition and Markets Authority said.
The regulator is concerned about price rises and quality issues.
VTech has until Wednesday to address the CMA’s concerns, or it will face an in-depth investigation, the CMA said.
An initial inquiry by the CMA found that the companies compete closely in supplying toddler products to retailers and there are few other competitors.
The CMA raised concerns that the deal may lead to a “substantial lessening of competition in the market”.
It added that, without the merger, both firms would have been close competitors in the supply of “child electronic reading systems,” with audio narration accompanying a physical book.
Kate Collyer of the CMA said: “VTech and LeapFrog are two of the largest and best known brands supplying electronic toys and learning products for children.
“Retailers see them as close rivals and rely on competition between the companies to keep prices down.
“We are concerned that the merger could lead to prices rising, the quality of products going downhill or the range on offer being reduced.
“Given this, the merger warrants an in-depth investigation – unless VTech is able to offer suitable undertakings to address our concerns.”
Full Content: Belfast Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas